Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Sequencing » Kuwaiti Firm Launches Breast Cancer Panel, Exome Services; Plans Move into Pre-implantation Dx

Kuwaiti Firm Launches Breast Cancer Panel, Exome Services; Plans Move into Pre-implantation Dx

Jul 17, 2013
|
Monica Heger
Premium

Kuwaiti molecular diagnostics firm Genatak has begun offering a targeted hereditary breast cancer panel and exome sequencing services for patients with cancer, undiagnosed genetic disorders, and individuals looking to understand disease risk.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Germany to Increase Viral Sequencing

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

Getting Used to It

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

Green Access at Science

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

Science Papers Examine Chronic Kidney Disease GWAS, Pneumonia Microbiome

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.

Feb
24
Featured Webinar

Case Study: Rapid Development and Manufacturing Scaleup of a Point-of-Care COVID-19 Test

Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints. 

What's Popular?

In Clinical Sequencing

  1. Pacific Biosciences CEO Discusses Q4 Results, New Sequencing Platforms at JP Morgan

  2. JP Morgan Healthcare Conference 2021, Day 1: Qiagen, Invitae, Agilent, Sema4, More

  3. Pacific Biosciences, Invitae to Develop Clinical Whole-Genome Sequencing Platform

  4. Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan

  5. PGDx, Qiagen Partner on Clinical Decision Support for Molecular Cancer Testing

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.